Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 182

1.

Markerless pancreatic tumor target localization enabled by deep learning.

Zhao W, Shen L, Han B, Yang Y, Cheng K, Toesca DA, Koong AC, Chang DT, Xing L.

Int J Radiat Oncol Biol Phys. 2019 Jun 13. pii: S0360-3016(19)30836-3. doi: 10.1016/j.ijrobp.2019.05.071. [Epub ahead of print]

PMID:
31201892
2.

The Trials (and Tribulations) of Complementary and Alternative Medicine in Oncology.

Ludmir EB, Jethanandani A, Mainwaring W, Miller AB, Lin TA, Espinoza AF, Verma V, VanderWalde NA, Grossberg AJ, Guadagnolo BA, Koong AC, Jagsi R, Thomas CR, Fuller CD.

J Natl Cancer Inst. 2019 Jun 4. pii: djz117. doi: 10.1093/jnci/djz117. [Epub ahead of print]

PMID:
31165160
3.

Factors Associated With Age Disparities Among Cancer Clinical Trial Participants.

Ludmir EB, Mainwaring W, Lin TA, Miller AB, Jethanandani A, Espinoza AF, Mandel JJ, Lin SH, Smith BD, Smith GL, VanderWalde NA, Minsky BD, Koong AC, Stinchcombe TE, Jagsi R, Gomez DR, Thomas CR Jr, Fuller CD.

JAMA Oncol. 2019 Jun 3. doi: 10.1001/jamaoncol.2019.2055. [Epub ahead of print]

PMID:
31158272
4.

Predicting Pancreatic Cancer Resectability and Outcomes Based on an Objective Quantitative Scoring System.

Toesca DAS, Jeffrey RB, von Eyben R, Pollom EL, Poullos PD, Poultsides GA, Fisher GA Jr, Visser BC, Koong AC, Chang DT.

Pancreas. 2019 May/Jun;48(5):622-628. doi: 10.1097/MPA.0000000000001314.

PMID:
31091207
5.

Novel EUS-guided brachytherapy treatment of pancreatic cancer with phosphorus-32 microparticles: first United States experience.

Bhutani MS, Cazacu IM, Luzuriaga Chavez AA, Singh BS, Wong FCL, Erwin WD, Tamm EP, Mathew GG, Le DB, Koay EJ, Taniguchi CM, Minsky BD, Pant S, Tzeng CD, Koong AC, Varadhachary GR, Katz MHG, Wolff RA, Fogelman DR, Herman JM.

VideoGIE. 2019 Apr 29;4(5):223-225. doi: 10.1016/j.vgie.2019.02.009. eCollection 2019 May. No abstract available.

6.

Effect of setup and inter-fraction anatomical changes on the accumulated dose in CT-guided breath-hold intensity modulated proton therapy of liver malignancies.

Yang Z, Chang Y, Brock KK, Cazoulat G, Koay EJ, Koong AC, Herman JM, Park PC, Poenisch F, Li Q, Yang K, Wu G, Anderson B, Ohrt AN, Li Y, Zhu XR, Zhang X, Li H.

Radiother Oncol. 2019 May;134:101-109. doi: 10.1016/j.radonc.2019.01.028. Epub 2019 Feb 6.

PMID:
31005203
7.

Enhancing clinical trial enrollment at MD Anderson Cancer Center satellite community campuses.

Ludmir EB, Adlakha EK, Chun SG, Reed VK, Arzu IY, Ahmad N, Bloom E, Chronowski GM, Delclos ME, Mayo LL, Schlembach PJ, Liao Z, Koong AC, Herman JM, Shah SJ.

Acta Oncol. 2019 Aug;58(8):1135-1137. doi: 10.1080/0284186X.2019.1600019. Epub 2019 Apr 8. No abstract available.

PMID:
30958082
8.

The relationship of lymphocyte recovery and prognosis of esophageal cancer patients with severe radiation-induced lymphopenia after chemoradiation therapy.

Deng W, Xu C, Liu A, van Rossum PSN, Deng W, Liao Z, Koong AC, Mohan R, Lin SH.

Radiother Oncol. 2019 Apr;133:9-15. doi: 10.1016/j.radonc.2018.12.002. Epub 2019 Jan 11.

PMID:
30935587
9.

Hypoxia imaging in upper gastrointestinal tumors and application to radiation therapy.

Tao R, Ager B, Lloyd S, Torgeson A, Denney M, Gaffney D, Kharofa J, Lin SH, Koong AC, Anzai Y, Hoffman JM.

J Gastrointest Oncol. 2018 Dec;9(6):1044-1053. doi: 10.21037/jgo.2018.09.15. Review.

10.

EUS-guided fiducial placement for GI malignancies: a systematic review and meta-analysis.

Coronel E, Cazacu IM, Sakuraba A, Luzuriaga Chavez AA, Uberoi A, Geng Y, Tomizawa Y, Saftoiu A, Shin EJ, Taniguchi CM, Koong AC, Herman JM, Bhutani MS.

Gastrointest Endosc. 2019 Apr;89(4):659-670.e18. doi: 10.1016/j.gie.2018.10.047. Epub 2018 Nov 13. Review.

PMID:
30445001
11.

Dose escalation for locally advanced pancreatic cancer: How high can we go?

Colbert LE, Rebueno N, Moningi S, Beddar S, Sawakuchi GO, Herman JM, Koong AC, Das P, Holliday EB, Koay EJ, Taniguchi CM.

Adv Radiat Oncol. 2018 Oct 23;3(4):693-700. doi: 10.1016/j.adro.2018.07.008. eCollection 2018 Oct-Dec.

12.

Stereotactic body radiation therapy for adrenal gland metastases: Outcomes and toxicity.

Toesca DAS, Koong AJ, von Eyben R, Koong AC, Chang DT.

Adv Radiat Oncol. 2018 May 24;3(4):621-629. doi: 10.1016/j.adro.2018.05.006. eCollection 2018 Oct-Dec.

13.

Automated Survival Prediction in Metastatic Cancer Patients Using High-Dimensional Electronic Medical Record Data.

Gensheimer MF, Henry AS, Wood DJ, Hastie TJ, Aggarwal S, Dudley SA, Pradhan P, Banerjee I, Cho E, Ramchandran K, Pollom E, Koong AC, Rubin DL, Chang DT.

J Natl Cancer Inst. 2018 Oct 21. doi: 10.1093/jnci/djy178. [Epub ahead of print]

PMID:
30346554
14.

Hmga2 is dispensable for pancreatic cancer development, metastasis, and therapy resistance.

Chiou SH, Dorsch M, Kusch E, Naranjo S, Kozak MM, Koong AC, Winslow MM, Grüner BM.

Sci Rep. 2018 Sep 18;8(1):14008. doi: 10.1038/s41598-018-32159-x.

15.

The role of bone marrow and spleen irradiation in the development of acute hematologic toxicity during chemoradiation for esophageal cancer.

Chin AL, Aggarwal S, Pradhan P, Bush K, von Eyben R, Koong AC, Chang DT.

Adv Radiat Oncol. 2018 Feb 21;3(3):297-304. doi: 10.1016/j.adro.2018.02.005. eCollection 2018 Jul-Sep.

16.

Papaverine and its derivatives radiosensitize solid tumors by inhibiting mitochondrial metabolism.

Benej M, Hong X, Vibhute S, Scott S, Wu J, Graves E, Le QT, Koong AC, Giaccia AJ, Yu B, Chen CS, Papandreou I, Denko NC.

Proc Natl Acad Sci U S A. 2018 Oct 16;115(42):10756-10761. doi: 10.1073/pnas.1808945115. Epub 2018 Sep 10. Erratum in: Proc Natl Acad Sci U S A. 2018 Dec 4;115(49):E11561.

17.

Dose escalation of radiotherapy in unresectable extrahepatic cholangiocarcinoma.

Elganainy D, Holliday EB, Taniguchi CM, Smith GL, Shroff R, Javle M, Raghav K, Kaseb A, Aloia TA, Vauthey JN, Tzeng CD, Herman JM, Koong AC, Krishnan SX, Minsky BD, Crane CH, Das P, Koay EJ.

Cancer Med. 2018 Oct;7(10):4880-4892. doi: 10.1002/cam4.1734. Epub 2018 Aug 27.

18.

Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected pancreatic cancer.

Yurgelun MB, Chittenden AB, Morales-Oyarvide V, Rubinson DA, Dunne RF, Kozak MM, Qian ZR, Welch MW, Brais LK, Da Silva A, Bui JL, Yuan C, Li T, Li W, Masuda A, Gu M, Bullock AJ, Chang DT, Clancy TE, Linehan DC, Findeis-Hosey JJ, Doyle LA, Thorner AR, Ducar MD, Wollison BM, Khalaf N, Perez K, Syngal S, Aguirre AJ, Hahn WC, Meyerson ML, Fuchs CS, Ogino S, Hornick JL, Hezel AF, Koong AC, Nowak JA, Wolpin BM.

Genet Med. 2019 Jan;21(1):213-223. doi: 10.1038/s41436-018-0009-5. Epub 2018 Jul 2.

PMID:
29961768
19.

Comparing Ablative Modalities for Hepatocellular Carcinoma: Cautions in Interpreting Big Data.

Smith GL, Das P, Herman JM, Koay EJ, Koong AC, Grossberg A, Ludmir E.

J Clin Oncol. 2018 Aug 20;36(24):2565-2566. doi: 10.1200/JCO.2018.78.5428. Epub 2018 Jun 26. No abstract available.

PMID:
29945520
20.

Altered exocrine function can drive adipose wasting in early pancreatic cancer.

Danai LV, Babic A, Rosenthal MH, Dennstedt EA, Muir A, Lien EC, Mayers JR, Tai K, Lau AN, Jones-Sali P, Prado CM, Petersen GM, Takahashi N, Sugimoto M, Yeh JJ, Lopez N, Bardeesy N, Fernandez-Del Castillo C, Liss AS, Koong AC, Bui J, Yuan C, Welch MW, Brais LK, Kulke MH, Dennis C, Clish CB, Wolpin BM, Vander Heiden MG.

Nature. 2018 Jun;558(7711):600-604. doi: 10.1038/s41586-018-0235-7. Epub 2018 Jun 20.

21.

18F-EF5 PET-based Imageable Hypoxia Predicts Local Recurrence in Tumors Treated With Highly Conformal Radiation Therapy.

Qian Y, Von Eyben R, Liu Y, Chin FT, Miao Z, Apte S, Carter JN, Binkley MS, Pollom EL, Harris JP, Prionas ND, Kissel M, Simmons A, Diehn M, Shultz DB, Brown JM, Maxim PG, Koong AC, Graves EE, Loo BW Jr.

Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):1183-1192. doi: 10.1016/j.ijrobp.2018.03.045. Epub 2018 Apr 18.

PMID:
29859786
22.

Management of Borderline Resectable Pancreatic Cancer.

Toesca DAS, Koong AJ, Poultsides GA, Visser BC, Haraldsdottir S, Koong AC, Chang DT.

Int J Radiat Oncol Biol Phys. 2018 Apr 1;100(5):1155-1174. doi: 10.1016/j.ijrobp.2017.12.287. Review.

PMID:
29722658
23.

High lymphocyte count during neoadjuvant chemoradiotherapy is associated with improved pathologic complete response in esophageal cancer.

Fang P, Jiang W, Davuluri R, Xu C, Krishnan S, Mohan R, Koong AC, Hsu CC, Lin SH.

Radiother Oncol. 2018 Sep;128(3):584-590. doi: 10.1016/j.radonc.2018.02.025. Epub 2018 Mar 9.

PMID:
29530432
24.

Present developments in reaching an international consensus for a model-based approach to particle beam therapy.

Prayongrat A, Umegaki K, van der Schaaf A, Koong AC, Lin SH, Whitaker T, McNutt T, Matsufuji N, Graves E, Mizuta M, Ogawa K, Date H, Moriwaki K, Ito YM, Kobashi K, Dekura Y, Shimizu S, Shirato H.

J Radiat Res. 2018 Mar 1;59(suppl_1):i72-i76. doi: 10.1093/jrr/rry008.

25.

A Human Genome-Wide RNAi Screen Reveals Diverse Modulators that Mediate IRE1α-XBP1 Activation.

Yang Z, Zhang J, Jiang D, Khatri P, Solow-Cordero DE, Toesca DAS, Koumenis C, Denko NC, Giaccia AJ, Le QT, Koong AC.

Mol Cancer Res. 2018 May;16(5):745-753. doi: 10.1158/1541-7786.MCR-17-0307. Epub 2018 Feb 9.

26.

Strategies for prediction and mitigation of radiation-induced liver toxicity.

Toesca DAS, Ibragimov B, Koong AJ, Xing L, Koong AC, Chang DT.

J Radiat Res. 2018 Mar 1;59(suppl_1):i40-i49. doi: 10.1093/jrr/rrx104.

27.

Inhibition of IRE1 results in decreased scar formation.

Boyko TV, Bam R, Jiang D, Wang Z, Bhatia N, Tran MC, Longaker MT, Koong AC, Yang GP.

Wound Repair Regen. 2017 Nov;25(6):964-971. doi: 10.1111/wrr.12603. Epub 2018 Feb 6.

28.

Multiplex Proximity Ligation Assay to Identify Potential Prognostic Biomarkers for Improved Survival in Locally Advanced Pancreatic Cancer Patients Treated With Stereotactic Body Radiation Therapy.

Rao AD, Liu Y, von Eyben R, Hsu CC, Hu C, Rosati LM, Parekh A, Ng K, Hacker-Prietz A, Zheng L, Pawlik TM, Laheru DA, Jaffee EM, Weiss MJ, Le DT, Hruban RH, De Jesus-Acosta A, Wolfgang CL, Narang AK, Chang DT, Koong AC, Herman JM.

Int J Radiat Oncol Biol Phys. 2018 Feb 1;100(2):486-489. doi: 10.1016/j.ijrobp.2017.10.001. Epub 2017 Oct 12.

PMID:
29157747
29.

Association of Alterations in Main Driver Genes With Outcomes of Patients With Resected Pancreatic Ductal Adenocarcinoma.

Qian ZR, Rubinson DA, Nowak JA, Morales-Oyarvide V, Dunne RF, Kozak MM, Welch MW, Brais LK, Da Silva A, Li T, Li W, Masuda A, Yang J, Shi Y, Gu M, Masugi Y, Bui J, Zellers CL, Yuan C, Babic A, Khalaf N, Aguirre A, Ng K, Miksad RA, Bullock AJ, Chang DT, Tseng JF, Clancy TE, Linehan DC, Findeis-Hosey JJ, Doyle LA, Thorner AR, Ducar M, Wollison B, Laing A, Hahn WC, Meyerson M, Fuchs CS, Ogino S, Hornick JL, Hezel AF, Koong AC, Wolpin BM.

JAMA Oncol. 2018 Mar 8;4(3):e173420. doi: 10.1001/jamaoncol.2017.3420. Epub 2018 Mar 8.

30.

Nonoperative Management of Rectal Cancer: A Modern Perspective.

Qian Y, Chin AL, Toesca DAS, Koong AC, Chang DT.

Oncology (Williston Park). 2017 Oct 15;31(10):e13-e22. Review.

31.

Impact of Intensity-Modulated Radiotherapy on Health Care Costs of Patients With Anal Squamous Cell Carcinoma.

Chin AL, Pollom EL, Qian Y, Koong AC, Chang DT.

J Oncol Pract. 2017 Dec;13(12):e992-e1001. doi: 10.1200/JOP.2017.024810. Epub 2017 Oct 16.

32.

A p53 Super-tumor Suppressor Reveals a Tumor Suppressive p53-Ptpn14-Yap Axis in Pancreatic Cancer.

Mello SS, Valente LJ, Raj N, Seoane JA, Flowers BM, McClendon J, Bieging-Rolett KT, Lee J, Ivanochko D, Kozak MM, Chang DT, Longacre TA, Koong AC, Arrowsmith CH, Kim SK, Vogel H, Wood LD, Hruban RH, Curtis C, Attardi LD.

Cancer Cell. 2017 Oct 9;32(4):460-473.e6. doi: 10.1016/j.ccell.2017.09.007.

33.

Lymph node metastases in resected pancreatic ductal adenocarcinoma: predictors of disease recurrence and survival.

Morales-Oyarvide V, Rubinson DA, Dunne RF, Kozak MM, Bui JL, Yuan C, Qian ZR, Babic A, Da Silva A, Nowak JA, Khalaf N, Brais LK, Welch MW, Zellers CL, Ng K, Chang DT, Miksad RA, Bullock AJ, Tseng JF, Swanson RS, Clancy TE, Linehan DC, Findeis-Hosey JJ, Doyle LA, Hornick JL, Ogino S, Fuchs CS, Hezel AF, Koong AC, Wolpin BM.

Br J Cancer. 2017 Dec 5;117(12):1874-1882. doi: 10.1038/bjc.2017.349. Epub 2017 Oct 5.

34.

Breathing New Life Into Hypoxia-Targeted Therapies for Non-Small Cell Lung Cancer.

Lin SH, Koong AC.

J Natl Cancer Inst. 2018 Jan 1;110(1). doi: 10.1093/jnci/djx163. No abstract available.

PMID:
28922792
35.

BLIMP1 Induces Transient Metastatic Heterogeneity in Pancreatic Cancer.

Chiou SH, Risca VI, Wang GX, Yang D, Grüner BM, Kathiria AS, Ma RK, Vaka D, Chu P, Kozak M, Castellini L, Graves EE, Kim GE, Mourrain P, Koong AC, Giaccia AJ, Winslow MM.

Cancer Discov. 2017 Oct;7(10):1184-1199. doi: 10.1158/2159-8290.CD-17-0250. Epub 2017 Aug 8.

36.

Introduction.

Koong AC, Tepper JE.

Semin Radiat Oncol. 2017 Jul;27(3):189. doi: 10.1016/j.semradonc.2017.03.005. Epub 2017 Mar 18. No abstract available.

PMID:
28577825
37.

Assessment of hepatic function decline after stereotactic body radiation therapy for primary liver cancer.

Toesca DAS, Osmundson EC, von Eyben R, Shaffer JL, Koong AC, Chang DT.

Pract Radiat Oncol. 2017 May - Jun;7(3):173-182. doi: 10.1016/j.prro.2016.10.003. Epub 2016 Oct 17.

PMID:
28343896
38.

Assessing local progression after stereotactic body radiation therapy for unresectable pancreatic adenocarcinoma: CT versus PET.

Toesca DA, Pollom EL, Poullos PD, Flynt L, Cui Y, Quon A, von Eyben R, Koong AC, Chang DT.

Pract Radiat Oncol. 2017 Mar - Apr;7(2):120-125. doi: 10.1016/j.prro.2016.09.002. Epub 2016 Sep 7.

PMID:
28274396
39.

The Impact of Intensity Modulated Radiation Therapy on Hospitalization Outcomes in the SEER-Medicare Population With Anal Squamous Cell Carcinoma.

Pollom EL, Wang G, Harris JP, Koong AC, Bendavid E, Bhattacharya J, Chang DT.

Int J Radiat Oncol Biol Phys. 2017 May 1;98(1):177-185. doi: 10.1016/j.ijrobp.2017.01.006. Epub 2017 Jan 7.

40.

Chemical Space Mimicry for Drug Discovery.

Yuan W, Jiang D, Nambiar DK, Liew LP, Hay MP, Bloomstein J, Lu P, Turner B, Le QT, Tibshirani R, Khatri P, Moloney MG, Koong AC.

J Chem Inf Model. 2017 Apr 24;57(4):875-882. doi: 10.1021/acs.jcim.6b00754. Epub 2017 Apr 3.

41.

ACR Appropriateness Criteria® Resectable Pancreatic Cancer.

Jones WE 3rd, Suh WW, Abdel-Wahab M, Abrams RA, Azad N, Das P, Dragovic J, Goodman KA, Jabbour SK, Konski AA, Koong AC, Kumar R, Lee P, Pawlik TM, Small W Jr, Herman JM; Expert Panel on Radiation OncologyGastrointestinal.

Am J Clin Oncol. 2017 Apr;40(2):109-117. doi: 10.1097/COC.0000000000000370. Review.

PMID:
28230650
42.

Cost-effectiveness of Stereotactic Body Radiation Therapy versus Radiofrequency Ablation for Hepatocellular Carcinoma: A Markov Modeling Study.

Pollom EL, Lee K, Durkee BY, Grade M, Mokhtari DA, Wahl DR, Feng M, Kothary N, Koong AC, Owens DK, Goldhaber-Fiebert J, Chang DT.

Radiology. 2017 May;283(2):460-468. doi: 10.1148/radiol.2016161509. Epub 2017 Jan 3.

43.

Comprehensive Analysis of the Unfolded Protein Response in Breast Cancer Subtypes.

Jiang D, Turner B, Song J, Li R, Diehn M, Le QT, Khatri P, Koong AC.

JCO Precis Oncol. 2017;2017. doi: 10.1200/PO.16.00073. Epub 2017 Jul 26.

44.

Reprogramming the immunological microenvironment through radiation and targeting Axl.

Aguilera TA, Rafat M, Castellini L, Shehade H, Kariolis MS, Hui AB, Stehr H, von Eyben R, Jiang D, Ellies LG, Koong AC, Diehn M, Rankin EB, Graves EE, Giaccia AJ.

Nat Commun. 2016 Dec 23;7:13898. doi: 10.1038/ncomms13898.

45.

Perfusion CT measurements predict tumor response in rectal carcinoma.

Kino A, Shaffer J, Maturen KE, Schmiedeskamp H, Koong AC, Chang DT, Fleischmann D, Kamaya A.

Abdom Radiol (NY). 2017 Apr;42(4):1132-1140. doi: 10.1007/s00261-016-0983-5.

PMID:
28008455
46.

Inhibition of the GAS6/AXL pathway augments the efficacy of chemotherapies.

Kariolis MS, Miao YR, Diep A, Nash SE, Olcina MM, Jiang D, Jones DS 2nd, Kapur S, Mathews II, Koong AC, Rankin EB, Cochran JR, Giaccia AJ.

J Clin Invest. 2017 Jan 3;127(1):183-198. doi: 10.1172/JCI85610. Epub 2016 Nov 28.

47.

Does radiotherapy still have a role in unresected biliary tract cancer?

Pollom EL, Alagappan M, Park LS, Whittemore AS, Koong AC, Chang DT.

Cancer Med. 2017 Jan;6(1):129-141. doi: 10.1002/cam4.975. Epub 2016 Nov 28.

48.

Central liver toxicity after SBRT: An expanded analysis and predictive nomogram.

Toesca DA, Osmundson EC, Eyben RV, Shaffer JL, Lu P, Koong AC, Chang DT.

Radiother Oncol. 2017 Jan;122(1):130-136. doi: 10.1016/j.radonc.2016.10.024. Epub 2016 Nov 16.

PMID:
27865544
49.

Identification of Doxorubicin as an Inhibitor of the IRE1α-XBP1 Axis of the Unfolded Protein Response.

Jiang D, Lynch C, Medeiros BC, Liedtke M, Bam R, Tam AB, Yang Z, Alagappan M, Abidi P, Le QT, Giaccia AJ, Denko NC, Niwa M, Koong AC.

Sci Rep. 2016 Sep 16;6:33353. doi: 10.1038/srep33353.

50.

Quantitative Analysis of (18)F-Fluorodeoxyglucose Positron Emission Tomography Identifies Novel Prognostic Imaging Biomarkers in Locally Advanced Pancreatic Cancer Patients Treated With Stereotactic Body Radiation Therapy.

Cui Y, Song J, Pollom E, Alagappan M, Shirato H, Chang DT, Koong AC, Li R.

Int J Radiat Oncol Biol Phys. 2016 Sep 1;96(1):102-9. doi: 10.1016/j.ijrobp.2016.04.034. Epub 2016 May 7.

PMID:
27511850

Supplemental Content

Loading ...
Support Center